Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00848133 · ClinicalTrials.gov registry record · Phase 4

A Comparison of Subvastus and Midvastus Approaches in Minimally-Invasive Total Knee Arthroplasty

A Phase 4 study of Total Knee Arthroplasty, sponsored by Sinai Hospital of Baltimore.

Completed
Registry status
Phase 4
Development phase
51
Enrollment target
1
Study location

NCT00848133 is a Phase 4 study of Total Knee Arthroplasty that has completed, run by Sinai Hospital of Baltimore. The registered enrollment target is 51 participants, below the 293-participant average among 29 other Total Knee Arthroplasty trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00848133, a Phase 4 study of Total Knee Arthroplasty, has completed, sponsored by Sinai Hospital of Baltimore.

COMPLETED
Registry status
Phase 4
Development phase
51 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study was to compare the early clinical outcomes of minimally invasive bilateral subvastus and midvastus approaches for total knee arthroplasty.

Conditions Studied

Interventions

  • PROCEDURE mini-midvastus surgical approach for total knee arthroplasty
  • PROCEDURE mini-subvastus surgical approach for total knee arthroplasty

Study Locations (1)

Illinois

  • Bonutti Clinic - Effingham

Trial Details

FieldValue
Enrollment Target 51 participants
Start Date 2004-07
Est. Completion 2009-02
Phase Phase 4

Sponsor

Sinai Hospital of Baltimore

1 total trials

What the Registry Record Tells You About NCT00848133

The ClinicalTrials.gov registry entry for NCT00848133 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 293-participant average among 29 other Total Knee Arthroplasty trials with a reported enrollment target (83% lower). The listed sponsor is Sinai Hospital of Baltimore, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Total Knee Arthroplasty appearing as the primary indexed condition, and to 2 interventions - of which mini-midvastus surgical approach for total knee arthroplasty is the first listed.

NCT00848133 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT00848133 about?

NCT00848133 is a clinical study titled "A Comparison of Subvastus and Midvastus Approaches in Minimally-Invasive Total Knee Arthroplasty". The purpose of this study was to compare the early clinical outcomes of minimally invasive bilateral subvastus and midvastus approaches for total knee arthroplasty.

What is the current status of trial NCT00848133?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 51 participants. The study started on 2004-07. Estimated completion is 2009-02.

What conditions does trial NCT00848133 study?

This clinical trial studies the following conditions: Total Knee Arthroplasty.

What interventions are being tested in trial NCT00848133?

The interventions under investigation include: mini-midvastus surgical approach for total knee arthroplasty (PROCEDURE), mini-subvastus surgical approach for total knee arthroplasty (PROCEDURE).

Who is sponsoring clinical trial NCT00848133?

This trial is sponsored by Sinai Hospital of Baltimore, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00848133 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Total Knee Arthroplasty

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.